Earlier this year, when TerraVia filed for Chapter 11 bankruptcy, Corbion made a $20 million “stalking horse” bid to acquire the company, establishing a baseline offer. The acquisition was finalized in late September, with Corbion’s cash offer and the assumption of TerraVia’s debt. This strategic move aligns with Corbion’s role as a supplier of ingredients such as lactic acid and functional blends of enzymes, emulsifiers, vitamins, and minerals across virtually all food categories. The addition of TerraVia’s microalgae platform enhances Corbion’s already extensive portfolio, enabling the company to leverage its scale to innovate with this increasingly popular ingredient and potentially reduce costs.
According to data from Grand View Research, the market for all microalgae products—encompassing food, fuel, and feed—was valued at approximately $1.38 billion in 2015. Credence Research forecasts that the global market for single-celled organisms will reach $44.7 billion by 2023, growing at a compound annual growth rate (CAGR) of over 5.2% from 2016 to 2023. With TerraVia now part of its operations, Corbion is well-positioned to boost the use of microalgae as an ingredient, further solidifying its presence in this sector. Microalgae is rich in protein and fatty acids, attributes that are increasingly appealing to health-conscious consumers, and it boasts a high level of sustainability.
Financial blogger Kevin Quon recently shared on Seeking Alpha that he purchased Corbion shares to continue investing in TerraVia’s technology. He noted that Corbion leads its sector and that TerraVia’s assets provide a unique opportunity for synergistic growth. Furthermore, he expressed confidence that TerraVia’s technology platform is more likely to thrive under Corbion’s guidance. In this context, the calcium citrate malate price may become more favorable as Corbion looks to innovate and expand its offerings, including the introduction of microalgae-rich products. As Corbion integrates TerraVia’s capabilities, the potential for competitive pricing, including calcium citrate malate price, could enhance its market position even further.